Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression
about
CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1α/CXCR4 axisThe Potential Role of the Proteases Cathepsin D and Cathepsin L in the Progression and Metastasis of Epithelial Ovarian CancerRole of mesenchymal cells in the natural history of ovarian cancer: a reviewE-cadherin's dark side: possible role in tumor progressionMechanisms involved in breast cancer liver metastasisR-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and MetastasisIdentification of ovarian cancer metastatic miRNAsRegulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4Targeting the EGF receptor for ovarian cancer therapy.Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burdenHydrogen peroxide mediates EGF-induced down-regulation of E-cadherin expression via p38 MAPK and snail in human ovarian cancer cells.E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer.Interplay between neural-cadherin and vascular endothelial-cadherin in breast cancer progression.Epidermal growth factor receptor-mediated membrane type 1 matrix metalloproteinase endocytosis regulates the transition between invasive versus expansive growth of ovarian carcinoma cells in three-dimensional collagenAnalysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity.Indometacin ameliorates high glucose-induced proliferation and invasion via modulation of e-cadherin in pancreatic cancer cells.Heterogeneous Cadherin Expression and Multicellular Aggregate Dynamics in Ovarian Cancer DisseminationDifferential expressions of adhesive molecules and proteases define mechanisms of ovarian tumor cell matrix penetration/invasion.Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition.Neuronal transcription factor Brn-3a(l) is over expressed in high-grade ovarian carcinomas and tumor cells from ascites of patients with advanced-stage ovarian cancerOvarian cancer development and metastasis.Uncovering molecular events associated with the chemosuppressive effects of flaxseed: a microarray analysis of the laying hen model of ovarian cancerThe cadherin switch in ovarian high-grade serous carcinoma is associated with disease progression.Assessment of ovarian cancer spheroid attachment and invasion of mesothelial cells in real time.Paclitaxel resistance and multicellular spheroid formation are induced by kallikrein-related peptidase 4 in serous ovarian cancer cells in an ascites mimicking microenvironment.Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells.Fibroblast growth factor 2 induces E-cadherin down-regulation via PI3K/Akt/mTOR and MAPK/ERK signaling in ovarian cancer cellsEmerging roles of Kruppel-like factor 6 and Kruppel-like factor 6 splice variant 1 in ovarian cancer progression and treatment.Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer.MUC16 mucin (CA125) regulates the formation of multicellular aggregates by altering β-catenin signalingIntegrin regulation of beta-catenin signaling in ovarian carcinoma.Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment.Immunohistological insight into the correlation between neuropilin-1 and epithelial-mesenchymal transition markers in epithelial ovarian cancer.Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells.Pygopus-2 promotes invasion and metastasis of hepatic carcinoma cell by decreasing E-cadherin expression.Evolution of adaptive phenotypic traits without positive Darwinian selection.The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migrationIncreased DNA methyltransferase activity and DNA methylation following Epidermal Growth Factor stimulation in ovarian cancer cells.Lysophosphatidic Acid disrupts junctional integrity and epithelial cohesion in ovarian cancer cells.Epithelial-mesenchymal transition in ovarian carcinoma
P2860
Q24337710-D8292136-B4F5-493B-B814-6DD199A351EAQ26776510-5AFBCF6B-DC52-4398-B2FC-C6165809A7F4Q26823555-38F2AB7E-8DDF-4925-ACFD-9D55115AB9B2Q26865483-43632EC0-767C-4F42-BEC6-FB88D0E5679FQ28084024-28814628-E6D3-48D3-A5F9-5571787777EDQ28265491-2B1FD1A7-31FC-4335-9F26-A7291DC12258Q28487932-495079D2-2188-4BEC-8F1C-EAB9310976AEQ28534173-C31FAE1F-E176-4B90-A7C7-48B182237389Q33570526-80BD80E8-DD72-4CD3-A044-39597417CDFEQ33628532-A9426D88-D9AB-436C-8618-73911885C34FQ33637424-B4A0FF91-A879-4FF6-9562-FCF6853272ACQ33726750-4C8541F0-DD00-475E-91E5-FFBD93098870Q33739421-5C89577C-DE68-46A0-B39E-CCB8F2F2A9C1Q33744931-39F7C6B9-CD2B-4C6D-B43F-8D76FEE5ADB9Q33802690-B45FF5B3-B597-491C-8C97-C474C9548DACQ33857813-B4B8AA4D-638A-4A39-8FEC-DEFCE35C2512Q33872469-9D153BB5-6DD5-4AAE-BD7E-C3D5852C2501Q33883716-ED3B659F-7DCD-47D7-804D-A45C24137D2FQ34008577-D5503789-7BC6-4DEB-87E9-85048E4F6A24Q34060699-FF3459EC-BAE1-4F5D-8F33-953768AC98E7Q34086819-7602DDC9-9DB6-492F-80F8-953A218E2AF5Q34151007-39B1FC33-C1C9-4E99-A8E2-8C068F73CB43Q34179788-44567EC3-98BD-4C03-B951-6BA9EABC7237Q34350732-B1146D35-263D-4CEA-940B-10062F4ECC02Q34602948-D49D0F1E-DA1F-48B8-BF8D-07F7441E10AAQ34643691-7CF6A565-CD60-4F6C-8FC0-6B1F654AEE5AQ34648726-E0F7A068-E61F-40EC-B47A-5D6E796E4047Q34698278-7B9DADFA-097B-4B61-8B05-70EA21750254Q34887528-CFA03509-011C-49D0-8AEC-2589C9DD0FE1Q34991249-598699F2-F537-4EA8-87E8-96EA673C6873Q35067867-8E3D83BA-BBB5-4563-AF9B-56FD39FC6A2CQ35098085-69895100-E13E-485C-A16D-0309D2B83983Q35172301-F9641758-DECA-40A8-8C10-245D5AA84010Q35767493-F295FE4E-F1C8-4A77-A81C-1F6AB950280AQ35793718-77C20C73-C27E-4E7D-900D-73BD77DD4F6AQ35854956-EC7C9DAA-4AA6-45E7-9BCE-F6030070BDC1Q35879981-0B4F2C0A-E6A4-433F-B803-76BFBFF93F5FQ35911242-47550E79-A478-4F67-83F3-CEA7DEBFC0B1Q35942558-70A635A0-CB76-40CD-AFD8-01286F254C99Q35971814-B0CFB971-ECB1-472C-92C1-CABA0D3C8AC1
P2860
Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Phenotypic plasticity of neopl ...... profiles in tumor progression
@ast
Phenotypic plasticity of neopl ...... profiles in tumor progression
@en
type
label
Phenotypic plasticity of neopl ...... profiles in tumor progression
@ast
Phenotypic plasticity of neopl ...... profiles in tumor progression
@en
prefLabel
Phenotypic plasticity of neopl ...... profiles in tumor progression
@ast
Phenotypic plasticity of neopl ...... profiles in tumor progression
@en
P2093
P2860
P1476
Phenotypic plasticity of neopl ...... profiles in tumor progression
@en
P2093
Laurie G Hudson
M Sharon Stack
Reema Zeineldin
P2860
P2888
P304
P356
10.1007/S10585-008-9171-5
P577
2008-04-09T00:00:00Z
P5875
P6179
1038951023